CPCCOEt
CAS: 179067-99-3
Rif. 3D-EHA06799
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione |
Informazioni sul prodotto
Nome:
CPCCOEt
Sinonimi:
- 7-(Hydroxyimino)Cyclopropa[B]Chromen-1A-Carboxylate Ethyl Ester
- 7-Hydroxyiminocyclopropan[B]Chromen-1A-Carboxylic Acid Ethyl Ester
- Benzo[b]cyclopropa[e]pyran-1a(1H)-carboxylic acid, 7,7a-dihydro-7-(hydroxyimino)-, ethyl ester
- Ethyl 7,7a-dihydro-7-(hydroxyimino)benzo[b]cyclopropa[e]pyran-1a(1H)-carboxylate
- ethyl (7E)-7-(hydroxyimino)-7,7a-dihydrocyclopropa[b]chromene-1a(1H)-carboxylate
Descrizione:
CPCCOEt is a glutamate receptor antagonist that binds to the metabotropic glutamate receptor subtype 2 (mGluR2) and blocks its activation. CPCCOEt has been shown to inhibit the death of neurons, axonal growth, and neuronal sprouting in vitro. It also prevents the neurotoxicity induced by glutamate or NMDA in cultured cortical neurons and microdialysis probes. CPCCOEt prevents the opening of voltage-dependent calcium channels, which leads to a decrease in cytosolic Ca2+ levels. This inhibition results in an increase in neuronal survival and protection against excitotoxic injury. CPCCOEt has been shown to have a protective effect on brain damage caused by stroke or cerebral ischemia in animal models.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
247.25 g/mol
Formula:
C13H13NO4
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
